LEVOMILNACIPRAN HYDROCHLORIDE | N204168 | ABBVIE INC
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
ALLERGAN SALES, LLC et al v. TORRENT PHARMACEUTICALS LIMITED et al 3 patentsANDA 210813levomilnacipran | D.N.J. | 2019-12-20 | Terminated 2020-12-07 | — |
| D.N.J. | 2019-04-12 | Terminated 2019-10-22 | — | |
FOREST LABORATORIES, LLC et al v. AUROBINDO PHARMA USA, INC. et al 3 patentsANDA 210826levomilnacipran | D.N.J. | 2017-11-15 | Terminated 2018-02-08 | — |
FOREST LABORATORIES, LLC et al v. AMNEAL PHARMACEUTICALS LLC et al 2 patentsANDA 210790levomilnacipran | D.N.J. | 2017-11-15 | Terminated 2018-02-09 | — |
FOREST LABORATORIES, LLC et al v. ZYDUS PHARMACEUTICALS (USA) INC. 3 patentsANDA 210857levomilnacipran | D.N.J. | 2017-10-31 | Terminated 2018-02-09 | — |
ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED et al v. PRINSTON PHARMACEUTICAL INC. et al 3 patentsANDA 210771levomilnacipran | D.N.J. | 2017-10-31 | Terminated 2021-09-14 | — |
FOREST LABORATORIES, LLC et al v. TORRENT PHARMACEUTICALS LIMITED et al 3 patentsANDA 210813levomilnacipran | D.N.J. | 2017-10-31 | Terminated 2018-02-09 | — |
FOREST LABORATORIES, LLC et al v. WEST-WARD PHARMACEUTICALS INTERNATIONAL LIMITED et al 3 patentsANDA 210732levomilnacipran | D.N.J. | 2017-10-31 | Terminated 2018-02-09 | — |
FOREST LABORATORIES, LLC, et al v. MSN LABORATORIES PRIVATE LIMITED et al 3 patentsANDA 210805levomilnacipran | D.N.J. | 2017-10-30 | Terminated 2018-02-09 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).